These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1323 related articles for article (PubMed ID: 17018787)
1. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787 [TBL] [Abstract][Full Text] [Related]
2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045 [TBL] [Abstract][Full Text] [Related]
3. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642 [TBL] [Abstract][Full Text] [Related]
5. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513 [TBL] [Abstract][Full Text] [Related]
6. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378 [TBL] [Abstract][Full Text] [Related]
7. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734 [TBL] [Abstract][Full Text] [Related]
9. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379 [TBL] [Abstract][Full Text] [Related]
10. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Tworoger SS; Sluss P; Hankinson SE Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055 [TBL] [Abstract][Full Text] [Related]
11. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200 [TBL] [Abstract][Full Text] [Related]
12. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Tworoger SS; Eliassen AH; Missmer SA; Baer H; Rich-Edwards J; Michels KB; Barbieri RL; Dowsett M; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2494-501. PubMed ID: 17164375 [TBL] [Abstract][Full Text] [Related]
13. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. Tworoger SS; Eliassen AH; Sluss P; Hankinson SE J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA; Borofsky ND; Massardo S; Orentreich N Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [TBL] [Abstract][Full Text] [Related]
16. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116 [TBL] [Abstract][Full Text] [Related]
17. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones. Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594 [TBL] [Abstract][Full Text] [Related]
18. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? Eliassen AH; Missmer SA; Tworoger SS; Hankinson SE J Clin Oncol; 2006 Apr; 24(12):1823-30. PubMed ID: 16567770 [TBL] [Abstract][Full Text] [Related]
19. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683 [TBL] [Abstract][Full Text] [Related]
20. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]